Stock Price Quote

WANBURY LTD.

NSE : WANBURYBSE : 524212ISIN CODE : INE107F01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE247.25-10.55 (-4.09 %)
PREV CLOSE ( ) 257.80
OPEN PRICE ( ) 262.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20577
TODAY'S LOW / HIGH ( )240.00 262.55
52 WK LOW / HIGH ( )132.55 325
NSE246.89-11.49 (-4.45 %)
PREV CLOSE( ) 258.38
OPEN PRICE ( ) 257.51
BID PRICE (QTY) 246.89 (200)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 180870
TODAY'S LOW / HIGH( ) 240.00 262.48
52 WK LOW / HIGH ( )131.2 323.53
1D 1M 3M 1Y 3Y 5Y
JavaScript chart by amCharts 3.4.2Show all

STOCK SUMMARY

Incorporation Year : 1988
Management Info
- Chairman - Managing Director
Registered Office

Address B S E L Tech Park,B - Wing, 10th Floor, Sector 30 A,Opp. Vashi Railway Station, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022-67942222 / 71963222

Email info@wanbury.com

Website www.wanbury.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE, Luxembourg

NEWS

24Mar Wanbury to launch two new products
Wanbury is all set to launch two new products, for formulation (Branded..
06Mar Wanbury informs about press release
Pursuant to Regulation 30 of SEBI Listing Regulations, Wanbury has infor..
08Jan Appointment of Director
Inter-alia considered and approved the following: (i) Appointment of Mr..
03Jan Wanbury completes Brazilian Health Aut
Wanbury has successfully completed the Brazilian Health Authority (ANVIS..
20Dec Wanbury informs about press release
Wanbury has informed that pursuant to Regulation 30 (6) of $EBI (Listing..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit12.1800000000004304
Gross Profit 12.9200000000004 307.81
Operating Profit 147.82729.93
Net Sales 1334.525756.5

ROLLING FORWARD P/E (EOD)

JavaScript chart by amCharts 3.4.2Show all
JavaScript chart by amCharts 3.4.212 Months Rolling Forward P/E (X)

EVENT CALENDAR

No Bonus available

peer group

Torrent Pharma (BSE)
peergroup  3284.75 (1.08%)
M.Cap ( in Cr)111170.87
Mankind Pharma (BSE)
peergroup  2450.40 (0.93%)
M.Cap ( in Cr)101098.24
Bal Pharma (BSE)
peergroup  121.70 (11.61%)
M.Cap ( in Cr)193.81
Sanofi India (BSE)
peergroup  6011.35 (0.19%)
M.Cap ( in Cr)13844.51
Source Natural Foods (BSE)
peergroup  193.95 (3.11%)
M.Cap ( in Cr)124.84

Shareholding Pattern

NON-INSTITUTION 59.4%
PROMOTERS 39.76%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Wanbury Ltd.

Wanbury Ltd. was incorporated in the year 1988. Its today's share price is 247.25. Its current market capitalisation stands at Rs 810.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5808.22 Cr and Total Income of Rs.5786.4 Cr. The company's management includes Manojkumar Khubchand Gursahani, Pallavur Sankar Dass Vaidyanathan, Jitendra J Gandhi, Mridul Mehta, Mohan Kumar Rayana, Anupama Vaidya, K Chandran.

It is listed on the BSE with a BSE Code of 524212 , NSE with an NSE Symbol of WANBURY and ISIN of INE107F01022. It's Registered office is at B S E L Tech Park,B - Wing, 10th Floor, Sector 30 A,Opp. Vashi Railway Station, VashiNavi Mumbai-400703, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Kapoor & Parekh Associates, V Parekh & Associates

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.